An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

Published:2023-01-02 Issue:1 Volume:16 Page:17-32
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Gómez-Seguí Inés¹,Pascual Izquierdo Cristina²^ORCID,Mingot Castellano María Eva³^ORCID,de la Rubia Comos Javier¹⁴^ORCID

Affiliation:

1. Servicio de Hematología y Hemoterapia, Hospital Universitari i Politècnic La Fe, Avda, Fernando Abril Martorell, 106, 46026, Valencia, Spain

2. Servicio de Hematología y Hemoterapia, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Gregorio Marañón, Calle Dr. Esquerdo 46, 28007, Madrid, Spain

3. Servicio de Hematología, Área de Banco de Sangre y Establecimiento de Tejidos, Hospital Universitario Virgen del Rocío, Calle Manuel Siurot s/n, 41013, Sevilla, Spain

4. School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2023.2159803

Reference161 articles.

1. Redefining outcomes in immune TTP: an international working group consensus report

2. Thrombotic thrombocytopenic purpura

3. Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura

4. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers

5. Incidence, diagnosis, and outcome of immune‐mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy;Blood;2024-05-02

2. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons;Expert Review of Hematology;2024-02-20

3. A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?;Journal of Clinical Medicine;2023-11-25

4. Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers;CNS Neuroscience & Therapeutics;2023-06-27

5. Reversible skin microvascular hyporeactivity in patients with immune-mediated thrombocytopenic thrombotic purpura;Critical Care;2023-03-21